choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • AtriCure Clinical Trials

AtriCure Clinical Trials Newsletter
  • Pulsed Field Ablation Market to Hit $2127.9 Million by 2032, Growing at 38.90% CAGR 04 Feb 2025 13:06 GMT

    … ™ EP System, ThermoCool™ SmartTouch Catheter) • AtriCure - (AtriClip™ Left Atrial Appendage … leading healthcare institutions and continuous clinical trials across North America, PFA technology …

  • AtriCure leadership explains $45M investment in Greater Cincinnati HQ 19 Aug 2024 11:12 GMT

    … low-cost environments.” Alternatively, AtriCure (Nasdaq: ATRC) might … local high schools. AtriCure is the largest employer … from,” he said. AtriCure focuses on cardiovascular conditions … company started the largest clinical trial ever done in cardiovascular …

  • Asset Prioritization in Pharma Domain: How In-Licensing Led to the Selection of a High-Value Game-Changing Asset for a Pharma Client 27 Jan 2025 23:10 GMT

    … client strategically align the clinical trial pipeline with growth objectives, … Laboratories, Johnson & Johnson, Atricure Inc., Microport Scientific Corporation, … analyze competitors' pipelines, clinical trial progress,, and market entry strategies …

  • AtriCure, Inc. (NASDAQ:ATRC) Q2 2024 Earnings Call Transcript 31 Jul 2024 12:48 GMT

    … clearances, competition, reimbursement and clinical trial outcomes. AtriCure’s results may differ materially … . This landmark and global clinical trial is expected to show a … in our LeAAPS clinical trial and resources focused on both clinical trials and new …

  • AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript 02 May 2024 19:48 GMT

    … approvals, clearances, reimbursement and clinical trial outcomes. AtriCure’s results may differ … . If successful, this massive clinical trial along with existing robust clinical … devices. Enrollment in the LeAAPS clinical trial has continued rapidly, with …

  • AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript 16 Feb 2024 16:37 GMT

    … approvals, clearances, reimbursement and clinical trial outcomes. AtriCure’s results may differ materially … Afib diagnosis through our LeAAPS clinical trial. The LeAAPS trial seeks … and expansion of our LeAAPS clinical trial and multiple product development …

  • AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results 15 Feb 2024 21:10 GMT

    … driven by investments in clinical trials and product development initiatives outpacing … following the presentation. About AtriCure AtriCure, Inc. provides innovative technologies … Financial Measures To supplement AtriCure’s condensed consolidated financial …

  • AtriCure Announces the First Patient Treated in the LeAAPS™ Clinical Trial 31 Jan 2023 13:10 GMT

    … , investigational device exemption (IDE) clinical trial to evaluate the safety and … atrial fibrillation and stroke.” About AtriCure AtriCure, Inc. provides innovative technologies … of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation …

  • Head-To-Head Comparison: AtriCure (NASDAQ:ATRC) and NovoCure (NASDAQ:NVCR) 10 Dec 2023 17:24 GMT

    … NovoCure is more favorable than AtriCure. Summary AtriCure beats NovoCure on 10 … also has ongoing or completed clinical trials investigating TTFields in brain metastases … Helier, Jersey. About AtriCure (Get Free Report) AtriCure, Inc. develops, manufactures …

  • AtriCure Releases 2023 ESG Report 14 Nov 2023 13:21 GMT

    … amp;I) practices. Launching key clinical trials and research studies focused on … employee learning and development. AtriCure created unique opportunities for educational … to view the report. About AtriCure AtriCure, Inc. provides innovative technologies for …

Satisfied with the content?

Continue to create your account.